Manon Ansart - Phd student at ARAMIS Lab (Inserm, Sorbonne University, CNRS, Inria)

Manon Ansart, Stéphane Epelbaum, Geoffroy Gagliardi, Olivier Colliot, Didier Dormont, et al.. Reduction of recruitment costs in preclinical AD trials. Validation of automatic pre-screening algorithm for brain amyloidosis. Statistical Methods in Medical Research, SAGE Publications, 2019, pp.096228021882303. ⟨10.1177/0962280218823036⟩. ⟨hal-01964942v2⟩

Manon Ansart, Ninon Burgos, Olivier Colliot, Didier Dormont, Stanley Durrleman. Prediction of future cognitive scores and dementia onset in Mild Cognitive Impairment patients. OHBM 2019 - Organization for Human Brain Mapping Conference, Jun 2019, Rome, Italy. ⟨hal-02098427v2⟩

Manon Ansart, Stéphane Epelbaum, Geoffroy Gagliardi, Olivier Colliot, Didier Dormont, et al.. Prediction of amyloidosis from neuropsychological and MRI data for cost effective inclusion of pre-symptomatic subjects in clinical trials. Multimodal Learning for Clinical Decision Support, Sep 2017, Quebec City, Canada. ⟨hal-01578422⟩

Manon Ansart, Stéphane Epelbaum, Olivier Colliot, Didier Dormont, Bruno Dubois, et al.. Selection of amyloid positive pre-symptomatic subjects using automatic analysis of neuropsychological and MRI data for cost effective inclusion procedures in clinical trials. Clinical Trials for Alzheimer's Disease, Nov 2017, Boston, United States. pp.295. ⟨hal-02098434v2⟩

Manon Ansart, Stéphane Epelbaum, Giulia Bassignana, Alexandre Bône, Simona Bottani, et al.. Predicting the Progression of Mild Cognitive Impairment Using Machine Learning: A Systematic and Quantitative Review. 2019. ⟨hal-02337815⟩